paclitaxel has been researched along with Carcinoma, Lewis Lung in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.82) | 18.2507 |
| 2000's | 13 (23.64) | 29.6817 |
| 2010's | 37 (67.27) | 24.3611 |
| 2020's | 4 (7.27) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, G; Ma, Y; Zhao, N | 1 |
| Dong, Y; Li, Z; Liu, G; Ma, Y; Wang, C; Wang, S | 1 |
| Hu, X; Li, X; Liu, G; Liu, Z; Ma, Y; Si, G; Tao, Y; Wang, S; Wu, Y; Yang, J; Zhao, N | 1 |
| Alam, MT; Hida, K; Hida, Y; Konno, S; Maishi, N; Nam, JM; Onodera, Y; Sakakibara-Konishi, J; Sato, M; Yanagawa-Matsuda, A | 1 |
| Babu, T; Gandin, V; Gibson, D; Ishan, M; Karmakar, S; Nemirovski, A; Yempala, T | 1 |
| Belousov, MV; Gur'ev, AM; Lopatina, KA; Razina, TG; Sadrikina, LA; Safonova, EA; Zueva, EP | 1 |
| Barash, U; Bhattacharya, U; Boyango, I; Gross-Cohen, M; Gutter-Kapon, L; Ilan, N; Kan, T; Liu, J; Sanderson, RD; Shaked, Y; Vlodavsky, I; Yang, SM | 1 |
| Cunnane, KA; Ding, H; Eber, MR; Fonseca, MM; Hsu, FC; Hsu, W; Ko, MC; Park, SH; Patel, CM; Peters, CM; Romero-Sandoval, EA; Shiozawa, Y; Strowd, RE; Wilson, JA | 1 |
| Luo, T; Qian, F; Que, Z; Tian, J; Yao, J; Yao, W; Yu, P; Zhang, Z; Zheng, D | 1 |
| Calleja, P; Espuelas, S; Irache, JM; Martínez-Oharriz, C; Zandueta, C | 1 |
| Ding, RL; Fu, SZ; He, WF; Lin, S; Liu, ZJ; Wen, QL; Wu, JB; Xie, F; Yang, LL | 1 |
| Belousov, MV; Fedorova, EP; Gur'ev, AM; Lopatina, KA; Razina, TG; Safonova, EA; Zueva, EP | 1 |
| Chen, XM; Fu, Q; Liu, SY; Lv, PP; Ma, GH; Wei, W; Yue, H; Yue, ZG | 1 |
| Agüeros, M; Calleja, P; Corrales, L; Espuelas, S; Irache, JM; Pío, R; Zabaleta, V | 1 |
| Barber, CL; Daenen, LG; He, H; Hofmann, JJ; Iruela-Arispe, ML; Lane, TF; Monvoisin, A; Radtke, F; Roodhart, JM; van Amersfoort, M; Voest, EE | 1 |
| Duan, Y; Ji, Q; Liu, P; Ma, Z; Qi, J; Zhang, J | 1 |
| Castiglioni, V; Cesca, M; Decio, A; Giavazzi, R; Rovida, A; Scanziani, E; Scarlato, V | 1 |
| Edwards, AD; Greenbaum, JM; Hariri, G; Harth, E; Merrill, TB; van der Ende, AE | 1 |
| Gutkin, DW; Han, B; Keskinov, AA; Ma, Y; Shurin, GV; Shurin, MR; Zhong, H | 1 |
| Bergfeld, SA; Blavier, L; DeClerck, YA | 1 |
| Elhissi, A; Sun, X; Wan, Y; Zhang, Z; Zheng, J | 1 |
| Le, V; Lin, S; Liu, J; Que, Z; Tian, J; Zhang, A; Zhang, L; Zheng, Y | 1 |
| Blatt, R; Cahal, S; Giladi, M; Itzhaki, A; Kirson, ED; Munster, M; Onn, A; Palti, Y; Porat, Y; Schneiderman, RS; Voloshin, T; Weinberg, U | 1 |
| Chen, JY; Hu, ML; Liao, JW; Liu, YZ; Yang, CM | 1 |
| Dong, J; Fu, Y; Gong, T; Lian, X; Song, X; Wan, Z; Xia, C; Yi, X; Zhang, Z | 1 |
| Bi, L; Jiao, Y; Jin, S; Li, HG; Tian, JH; Wang, Q; You, J; Zheng, Z | 1 |
| Cherkezova, R; Fushimi, M; Hirota, K; Hristova, T; Koda, T; Koseva, N; Kuniya, M; Makino, K; Mitova, V; Terada, H; Troev, K; Yusa, S | 1 |
| Andronova, NV; Bonartsev, AP; Bonartseva, GA; Borisova, JA; Kalishjan, MS; Mahina, TK; Myshkina, VL; Shaitan, KV; Smirnova, GB; Treshalina, HM; Yakovlev, SG; Zernov, AL; Zharkova, II | 1 |
| Bosquillon, C; Loira-Pastoriza, C; Luo, T; Muccioli, GG; Patil, HP; Ucakar, B; Vanbever, R | 1 |
| Benezra, R; Bertolini, F; Colleoni, M; Daenen, LG; Emmenegger, U; Henke, E; Kerbel, RS; Langenberg, MH; Man, S; Mancuso, P; Roodhart, JM; Shaked, Y; Strieter, RM; Tang, T; Voest, EE; Witte, L; Xu, P; Zhu, Z | 1 |
| Barnett, J; Cuthbertson, A; Morrison, MS; Ricketts, SA; Tessier, J; Wedge, SR | 1 |
| Colson, YL; Gaffey, A; Grinstaff, MW; Griset, AP; Liu, R; Walpole, J | 1 |
| Bohnenkamp, H; Bruns, CJ; Dellian, M; Eichhorn, ME; Guenzi, E; Ischenko, I; Jauch, KW; Luedemann, S; Michaelis, U; Papyan, A; Preissler, G; Strieth, S; Werner, A | 1 |
| Chen, L; Huang, G | 1 |
| Batrakova, EV; Bronich, TK; Jordan, R; Kabanov, AV; Li, S; Luxenhofer, R; Roques, C; Schulz, A | 1 |
| Hu, X; Jing, X; Liu, S; Song, X; Tong, T; Wan, Y; Zheng, Y | 1 |
| Hallahan, DE; Han, Z; Hariri, G; Wang, H; Yan, H | 1 |
| Chen, L; Huang, G; Huang, X; Song, H | 1 |
| Demers, M; Ho-Tin-Noé, B; Schatzberg, D; Wagner, DD; Yang, JJ | 1 |
| Chu, YW; Liu, N; Xiong, SD; Zheng, YJ; Zhu, Y | 1 |
| Benayoun, L; Bril, R; Gingis-Velitski, S; Kerbel, RS; Man, S; Milsom, C; Munster, M; Shaked, Y; Voloshin, T | 1 |
| Hu, X; Jing, X; Liu, S; Song, X; Wan, Y; Zheng, Y | 1 |
| Ding, M; Fu, Q; Fu, X; He, X; Li, J; Tan, H; Zhou, L | 1 |
| Corbett, JT; Lindsey, JM; Nagatomi, SD; Olbrich, JM; Shalaby, SW; Shalaby, WS; Tate, PL | 1 |
| Dekel, Y; Margalit, R; Melikhov, D; Peer, D | 1 |
| Abbara, C; Bonhomme-Faivre, L; Farinotti, R; Hosten, B; Rouchon, C | 1 |
| Hattori, H; Hayashi, T; Ishihara, M; Ishizuka, T; Kikuchi, M; Maehara, T; Matsui, T; Nakamura, S; Obara, K; Ozeki, Y; Saito, Y; Takase, B; Yura, H | 1 |
| Ge, ZQ; Liu, CX; Yang, WY; Yin, DS; Yuan, YJ | 1 |
| Bonhomme-Faivre, L; Bouquet, C; Challuau, D; Di Palma, M; Farinotti, R; Gil, S; Hosten, B; Marion, S; Perricaudet, M | 1 |
| Hou, M; Qiu, M; Yi, C | 1 |
| Chen, YG; Cheng, ZD | 1 |
| Ding, Q; Guo, Q; Ping, Q; Qu, G; Shen, Z; Sun, Y; Wu, X; Yao, Z; Yuan, S; Zhang, C; Zhou, H | 1 |
| Bai, CQ; Guo, HL; Song, YF; Wang, DT | 1 |
| Herbst, RS; Takeuchi, H; Teicher, BA | 1 |
| Maekawa, R; Uchida, N; Yamada, H; Yoshioka, T | 1 |
55 other study(ies) available for paclitaxel and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Conjugate (MTC-220) of muramyl dipeptide analogue and paclitaxel prevents both tumor growth and metastasis in mice.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Bone Marrow Cells; Breast Neoplasms; Carcinoma, Lewis Lung; Cell Division; Cell Line, Tumor; Chromatography, High Pressure Liquid; Cytokines; Dipeptides; Female; Humans; Inflammation Mediators; Mice; Mice, Nude; Neoplasm Metastasis; Paclitaxel | 2011 |
Antagonizing NOD2 Signaling with Conjugates of Paclitaxel and Muramyl Dipeptide Derivatives Sensitizes Paclitaxel Therapy and Significantly Prevents Tumor Metastasis.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Drug Synergism; Mice; Neoplasm Metastasis; Nod2 Signaling Adaptor Protein; Paclitaxel; Signal Transduction | 2017 |
Discovery of 1,4-Benzodiazepine-2,5-dione (BZD) Derivatives as Dual Nucleotide Binding Oligomerization Domain Containing 1/2 (NOD1/NOD2) Antagonists Sensitizing Paclitaxel (PTX) To Suppress Lewis Lung Carcinoma (LLC) Growth in Vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepines; Carcinoma, Lewis Lung; Cytokines; Drug Screening Assays, Antitumor; Humans; Macrophages; Male; Mice, Inbred C57BL; Molecular Targeted Therapy; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Paclitaxel; Protein Domains; Structure-Activity Relationship | 2017 |
Angiogenic inhibitor pre-administration improves the therapeutic effects of immunotherapy.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Lewis Lung; Immunotherapy; Lung Neoplasms; Mice; Paclitaxel; Tumor Microenvironment | 2023 |
Expanding the Arsenal of Pt
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carbonates; Carcinoma, Lewis Lung; Cell Line, Tumor; Cisplatin; Deoxycytidine; Drug Screening Assays, Antitumor; Estramustine; Female; Gemcitabine; Humans; Ligands; Male; Mice, Inbred C57BL; Organoplatinum Compounds; Paclitaxel; Prodrugs; Prohibitins; Structure-Activity Relationship | 2019 |
Correction of Damaging Effects of Cisplatin-Containing Polychemotherapy on the Intestinal Epithelium with Tussilago farfara L. Polysaccharides.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cisplatin; Eosine Yellowish-(YS); Etoposide; Female; Hematoxylin; Histocytochemistry; Intestinal Mucosa; Irinotecan; Mice; Mice, Inbred C57BL; Paclitaxel; Plant Extracts; Polysaccharides; Tussilago | 2019 |
Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth.
Topics: Animals; Antineoplastic Agents; Carcinogenesis; Carcinoma, Lewis Lung; Cell Line, Tumor; Cisplatin; DNA Methylation; Enzyme Assays; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glucuronidase; Histones; Intracellular Signaling Peptides and Proteins; Macrophage Activation; Macrophages; Mice; Mice, Knockout; Paclitaxel; Tumor Microenvironment | 2020 |
Usefulness of the measurement of neurite outgrowth of primary sensory neurons to study cancer-related painful complications.
Topics: A549 Cells; Adult; Animals; Antineoplastic Agents, Phytogenic; Cancer Pain; Carcinoma, Lewis Lung; Cells, Cultured; Female; Humans; Macaca mulatta; Male; Mice; Mice, Inbred C57BL; Neuronal Outgrowth; Paclitaxel; Sensory Receptor Cells | 2021 |
Paclitaxel-loaded and folic acid-modified PLGA nanomedicine with glutathione response for the treatment of lung cancer.
Topics: Animals; Carcinoma, Lewis Lung; Delayed-Action Preparations; Folic Acid; Glutathione; Lung Neoplasms; Mice; Nanomedicine; Paclitaxel; Polylactic Acid-Polyglycolic Acid Copolymer | 2021 |
A combination of nanosystems for the delivery of cancer chemoimmunotherapeutic combinations: 1-Methyltryptophan nanocrystals and paclitaxel nanoparticles.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line; Female; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Mice, Inbred C57BL; Nanoparticles; Paclitaxel; Particle Size; Solubility; Tryptophan; X-Ray Diffraction | 2017 |
In vivo antitumor effect of endostatin-loaded chitosan nanoparticles combined with paclitaxel on Lewis lung carcinoma.
Topics: Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Chitosan; Endostatins; Mice; Mice, Inbred C57BL; Nanoparticles; Paclitaxel; Vascular Endothelial Growth Factor A | 2017 |
Modification of the Myelotoxic and Antitumor Effects of Polychemotherapy by Polysaccharides from Tussilago farfara L.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cisplatin; Female; Filgrastim; Granulocytes; Hematologic Agents; Leukocyte Count; Mice; Mice, Inbred C57BL; Paclitaxel; Plant Extracts; Polysaccharides; Treatment Outcome; Tumor Burden; Tussilago | 2018 |
Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression.
Topics: Absorption; Animals; Antineoplastic Agents; Caco-2 Cells; Carbocyanines; Carcinoma, Lewis Lung; Cell Death; Cell Proliferation; Chitosan; Drug Delivery Systems; Endocytosis; Flow Cytometry; Gene Silencing; Gene Transfer Techniques; Humans; Intracellular Space; Male; Mice; Nanoparticles; Neoplasms; Paclitaxel; Permeability; Quaternary Ammonium Compounds; RNA, Small Interfering; Telomerase; Tissue Distribution; Xenograft Model Antitumor Assays | 2013 |
[Mucopenetrating nanoparticles: vehicles for the oral administration of paclitaxel].
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Chemistry, Pharmaceutical; Intestinal Absorption; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Nanoparticles; Neoplasm Transplantation; Paclitaxel; Pharmaceutical Vehicles; Polyethylene Glycols | 2013 |
Notch1 regulates angio-supportive bone marrow-derived cells in mice: relevance to chemoresistance.
Topics: Animals; Antigens, CD; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bone Marrow Cells; Cadherins; Carcinoma, Lewis Lung; Cisplatin; Colorectal Neoplasms; Drug Resistance, Neoplasm; Mammary Neoplasms, Animal; Mice; Mice, 129 Strain; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Mice, Transgenic; Paclitaxel; Receptor, Notch1; Xenograft Model Antitumor Assays | 2013 |
Antitumor efficacy of paclitaxel-loaded polylactide/ poly(ethylene glycol) nanoparticles combination with exercise in tumor-bearing mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Lung Neoplasms; Mice; Nanoparticles; Paclitaxel; Physical Conditioning, Animal; Polyesters; Polyethylene Glycols | 2013 |
Chemotherapy counteracts metastatic dissemination induced by antiangiogenic treatment in mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Movement; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Indoles; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Paclitaxel; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Topotecan | 2013 |
Sequential targeted delivery of paclitaxel and camptothecin using a cross-linked "nanosponge" network for lung cancer chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Carcinoma, Lewis Lung; Cell Cycle; Cell Proliferation; Cross-Linking Reagents; Drug Carriers; Drug Delivery Systems; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Paclitaxel; Peptide Fragments; Radiation, Ionizing; Tumor Cells, Cultured | 2014 |
Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cancer Vaccines; Carcinoma, Lewis Lung; Cells, Cultured; Dendritic Cells; Flow Cytometry; Immunotherapy; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myeloid Cells; Paclitaxel; Receptors, Chemokine; rho GTP-Binding Proteins; T-Lymphocytes, Regulatory; Toll-Like Receptor 4; Tumor Microenvironment | 2014 |
Bone marrow-derived mesenchymal stromal cells promote survival and drug resistance in tumor cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coculture Techniques; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Experimental; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; NIH 3T3 Cells; Paclitaxel | 2014 |
Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid nanoparticles.
Topics: Animals; Carcinoma, Lewis Lung; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Drug Delivery Systems; Lipids; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Paclitaxel; Peptide Fragments; Polyethylene Glycols; Xenograft Model Antitumor Assays | 2014 |
Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Coculture Techniques; Disease Progression; Drug Screening Assays, Antitumor; Female; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice, Inbred C57BL; Neoplasm Transplantation; Paclitaxel; Saponins; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Triterpenes; Tryptophan; Tumor Burden; Tumor Escape | 2014 |
Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Proliferation; Cisplatin; Combined Modality Therapy; Electric Stimulation Therapy; Glutamates; Guanine; Humans; In Vitro Techniques; Lung Neoplasms; Mice; Mice, Inbred C57BL; Paclitaxel; Pemetrexed; Survival Rate; Treatment Outcome; Tumor Cells, Cultured | 2014 |
Alpha-carotene inhibits metastasis in Lewis lung carcinoma in vitro, and suppresses lung metastasis and tumor growth in combination with taxol in tumor xenografted C57BL/6 mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Carotenoids; Focal Adhesion Kinase 1; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Paclitaxel; Plasminogen Activator Inhibitor 1; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Urokinase-Type Plasminogen Activator; Xenograft Model Antitumor Assays | 2015 |
Co-delivery of Pirarubicin and Paclitaxel by Human Serum Albumin Nanoparticles to Enhance Antitumor Effect and Reduce Systemic Toxicity in Breast Cancers.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Carcinoma, Lewis Lung; Cell Cycle; Cell Proliferation; Doxorubicin; Drug Delivery Systems; Drug Therapy, Combination; Female; Flow Cytometry; Gastrointestinal Diseases; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nanoparticles; Paclitaxel; Rats, Sprague-Dawley; Serum Albumin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
[Inhibitory Effect of Feiji Recipe on IDO Induced Immune Escape on the Murine Model of Lewis Lung Carcinoma].
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Drugs, Chinese Herbal; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lung Neoplasms; Mice; Mice, Inbred C57BL; Paclitaxel; T-Lymphocytes, Regulatory | 2016 |
Polyphosphoester-based Paclitaxel Complexes: Biological Evaluation.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Survival; Drug Carriers; Esters; Humans; Mice, Inbred C57BL; Paclitaxel; Polymers | 2016 |
New Poly(3-hydroxybutyrate) Microparticles with Paclitaxel Sustained Release for Intraperitoneal Administration.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Lewis Lung; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hydroxybutyrates; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Mice; Molecular Structure; Paclitaxel; Particle Size; Polyesters; Prohibitins; Structure-Activity Relationship; Surface Properties; Tumor Cells, Cultured | 2017 |
PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Female; Mice; Mice, Inbred C57BL; Paclitaxel; Polyethylene Glycols | 2016 |
Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Breast Neoplasms; Carcinoma, Lewis Lung; Cell Proliferation; Chemokine CXCL12; Deoxycytidine; Drug Therapy, Combination; Endothelial Cells; Female; Gemcitabine; Humans; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Paclitaxel; Stem Cells; Tumor Burden; Vascular Endothelial Growth Factor A | 2008 |
Use of a novel Arg-Gly-Asp radioligand, 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Mice; Neoplasms; Oligopeptides; Paclitaxel; Peptides; Polyethylene Glycols; Positron-Emission Tomography; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Tissue Distribution; Triazoles | 2009 |
Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system.
Topics: Animals; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Delivery Systems; Drug Screening Assays, Antitumor; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Lung Neoplasms; Mice; Nanoparticles; Paclitaxel; Polymers | 2009 |
Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cisplatin; Cricetinae; Deoxycytidine; Drug Administration Schedule; Drug Delivery Systems; Gemcitabine; Humans; Immunohistochemistry; Lipopeptides; Liposomes; Lung Neoplasms; Male; Mice; Neovascularization, Pathologic; Paclitaxel; Pancreatic Neoplasms | 2010 |
Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma.
Topics: Animals; Carcinoma, Lewis Lung; Cell Division; Combined Modality Therapy; DNA Primers; Endostatins; Endothelial Growth Factors; Humans; Mice; Mice, Inbred C57BL; Microcirculation; Paclitaxel; Pericytes; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Thrombospondins; Vascular Endothelial Growth Factor A | 2010 |
Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Survival; Complement Activation; Female; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Mice, Inbred C57BL; Micelles; Neoplasms; Oxazoles; Paclitaxel; Polymers; Solubility | 2010 |
Anti-tumor activity of biodegradable polymer-paclitaxel conjugate micelles on Lewis lung cancer mice models.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Lewis Lung; Cell Line, Tumor; Drug Carriers; Female; Folic Acid; Injections, Intravenous; Mice, Inbred C57BL; Micelles; Nanoparticles; Neoplasm Transplantation; Paclitaxel; Polymers; Treatment Outcome; Tumor Burden | 2011 |
Radiation-guided drug delivery to mouse models of lung cancer.
Topics: Albumins; Amino Acid Sequence; Animals; Biological Availability; Carcinoma, Large Cell; Carcinoma, Lewis Lung; Cell Line, Tumor; Disease Models, Animal; Drug Delivery Systems; Guinea Pigs; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Molecular Sequence Data; Paclitaxel; Peptides; Rabbits; Tissue Distribution; Xenograft Model Antitumor Assays | 2010 |
Preconditioning chemotherapy with paclitaxel and cisplatin enhances the antitumor activity of cytokine induced-killer cells in a murine lung carcinoma model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Line, Tumor; Cisplatin; Combined Modality Therapy; Cytokine-Induced Killer Cells; Cytotoxicity, Immunologic; Female; Immunotherapy, Adoptive; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred C57BL; Paclitaxel; Spleen; T-Lymphocytes, Regulatory; Transplantation Conditioning | 2011 |
Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice.
Topics: Animals; Antineoplastic Agents; Capillary Permeability; Carcinoma, Lewis Lung; Female; Immunohistochemistry; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Paclitaxel; Thrombocytopenia; Tissue Distribution | 2011 |
CD4+Foxp3+ regulatory T-cell impairment by paclitaxel is independent of toll-like receptor 4.
Topics: Animals; Carcinoma, Lewis Lung; Cell Count; Cell Survival; Cytokines; Female; Forkhead Transcription Factors; Mice; Mice, Inbred C57BL; Mice, Knockout; Paclitaxel; Spleen; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Toll-Like Receptor 4 | 2011 |
G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonist.
Topics: Animals; Antineoplastic Agents; Benzylamines; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclams; Drug Combinations; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Heterocyclic Compounds; Humans; Immunohistochemistry; Inflammatory Breast Neoplasms; Injections, Intraperitoneal; Matrix Metalloproteinase 2; Mice; Mice, Knockout; Neovascularization, Pathologic; Paclitaxel; Receptors, CXCR4; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2011 |
Composite micelles consisting of paclitaxel- and folic acid-carrying copolymers for treatment of Lewis lung cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Carriers; Drug Compounding; Female; Folic Acid; Injections, Intravenous; Kinetics; Lactic Acid; Light; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Micelles; Microscopy, Electron, Transmission; Paclitaxel; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Polypropylenes; Scattering, Radiation; Solubility; Technology, Pharmaceutical | 2011 |
Nontoxic gemini cationic biodegradable polyurethane drug carriers: synthesis, self-assembly and in vitro cytotoxicity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Kinetics; Light; Mice; Micelles; Microscopy, Electron, Transmission; Paclitaxel; Particle Size; Polyesters; Polyurethanes; Scattering, Radiation; Solubility; Spectrometry, Fluorescence; Technology, Pharmaceutical | 2011 |
Injectable in situ forming controlled release implant composed of a poly-ether-ester-carbonate and applications in the field of chemotherapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbonates; Carcinoma, Lewis Lung; Cell Line, Tumor; Delayed-Action Preparations; Female; Injections; Lung Neoplasms; Mice; Mice, Inbred C57BL; Paclitaxel | 2012 |
Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Lewis Lung; Cell Line, Tumor; Disease Progression; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Fluoxetine; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Mitomycin; Neoplasms, Experimental; Paclitaxel; Tissue Distribution; Vinblastine; Xenograft Model Antitumor Assays | 2004 |
Enhanced oral bioavailability of paclitaxel by recombinant interleukin-2 in mice with murine Lewis lung carcinoma.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Carcinoma, Lewis Lung; Drug Synergism; Female; Interleukin-2; Lung Neoplasms; Mice; Mice, Inbred C57BL; Paclitaxel; Recombinant Proteins | 2004 |
Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug Stability; Endothelial Cells; Hydrogels; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neovascularization, Pathologic; Paclitaxel; Photochemistry; Skin Neoplasms | 2005 |
Inhibition of tumor metastasis in vivo by combination of paclitaxel and hyaluronic acid.
Topics: Amino Acid Sequence; Animals; Antineoplastic Combined Chemotherapy Protocols; Ascites; Blood Proteins; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Movement; Electrophoresis, Gel, Two-Dimensional; Female; Hyaluronic Acid; Injections, Intraperitoneal; Injections, Intravenous; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Neoplasm Metastasis; Paclitaxel; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Survival Analysis; Swine; Treatment Outcome; Uterine Cervical Neoplasms | 2006 |
Recombinant interleukin-2 pre-treatment increases anti-tumor response to paclitaxel by affecting lung P-glycoprotein expression on the Lewis lung carcinoma.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Carcinoma, Lewis Lung; Combined Modality Therapy; Female; Injections, Subcutaneous; Interleukin-2; Lung; Mice; Mice, Inbred C57BL; Paclitaxel; Recombinant Proteins | 2006 |
[Combined low-dose chemotherapy inhibiting angiogenesis and growth of Lewis lung cancinoma xenografts in mice].
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cyclophosphamide; Female; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Paclitaxel; Random Allocation; Vascular Endothelial Growth Factor A | 2006 |
[Effect of acupuncture combined with intraperitoneal injection of paclitaxel on apoptosis in Lewis mice with lung carcinoma].
Topics: Acupuncture Therapy; Animals; Apoptosis; Carcinoma, Lewis Lung; Combined Modality Therapy; Female; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Paclitaxel | 2007 |
Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
Topics: Alkanesulfonic Acids; Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Biological Availability; Carcinoma, Ehrlich Tumor; Carcinoma, Lewis Lung; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Hemolysis; Humans; Liver Neoplasms, Experimental; Male; Materials Testing; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Micelles; Paclitaxel; Rats; Rats, Sprague-Dawley; Safety; Sarcoma 180; Tissue Distribution | 2008 |
[Inhibitory effect of huangqi and dangshen extraction with pacilitaxel on metastasis and angiogenesis on mouse Lewis lung carcinoma model].
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Codonopsis; Drugs, Chinese Herbal; Kaplan-Meier Estimate; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neovascularization, Pathologic; Paclitaxel | 2008 |
Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Carboplatin; Carcinoma, Lewis Lung; Cell Survival; Colony-Forming Units Assay; Cyclohexanes; Drug Synergism; Drug Therapy, Combination; Female; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Minocycline; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Paclitaxel; Sesquiterpenes | 1998 |
Sequence-dependent antitumor efficacy of combination chemotherapy with nedaplatin, a newly developed platinum, and paclitaxel.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carboplatin; Carcinoma, Lewis Lung; Cisplatin; Female; Liver; Lung Neoplasms; Mice; Mice, Inbred C57BL; Organoplatinum Compounds; Paclitaxel; Time Factors | 2001 |